Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
David Gonzalez-De-OlanoPaula Navarro-NavarroJavier I Muñoz-GonzálezLaura Sánchez-MuñozAna HenriquesAna de-Andrés-MartínDolores Peralta-ArjonillaAndrea MayadoMaria JaraAndrés C García-MonteroAlberto OrfaoIván Álvarez-TwosePublished in: Allergy (2023)
The frequency of HAT in MC disorders varies according to the diagnostic subtype of the disease. HAT does not imply a higher risk (and severity) of anaphylaxis in mastocytosis patients in whom anaphylaxis is not part of the presenting symptoms of the disease.